Notably, an elevated SREBP-2 mRNA expression level was measured in the steatosis state of HepG2 cells, implying that SREBP-2 may be involved in the induction of NAFLD (Figure 3d). The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatotic liver disease.